The use and safety of XGEVA or Zoledronic acid in clinical practice among Chinese patients with bone metastases from breast, lung, or prostate cancer – a retrospective cohort study within Taiwan’s Health Insurance Research Database (20190412)

First published 12/03/2021

Last updated 02/07/2024

EU PAS number:

EUPAS39611

Study

Finalised

Documents

Study protocol

Initial protocol

EUPAS39611-40005

English (842.35 KB - PDF)View document

Study results

20190412 Observational Research Study Report Published Report_Redacted

English (681.65 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs